186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma

Blood. 2004 Feb 1;103(3):1175. doi: 10.1182/blood-2003-10-3593.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Combined Modality Therapy
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation
  • Radioimmunotherapy
  • Radioisotopes / therapeutic use
  • Rhenium / therapeutic use
  • Rituximab
  • Transplantation, Autologous

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Radioisotopes
  • Rituximab
  • Rhenium